Latest News
News Functions
Additional Functions
12 November 2021
HumanOptics AG
HumanOptics AG: Merger Squeeze-out registered
22 May 2021
HumanOptics AG
HumanOptics AG: Cash compensation for merger squeeze-out determined at EUR 8.71 per share
19 May 2021
HumanOptics AG
HumanOptics AG: Raising of earnings forecast for financial year 2020/2021
21 January 2021
HumanOptics AG
HumanOptics AG: Request by the main shareholder to execute a merger squeeze-out
15 January 2021
HumanOptics AG
HumanOptics AG appointed Stefan Kremer as the new Chief Executive Officer (CEO)
30 December 2020
HumanOptics AG
DGAP-DD: HumanOptics AG english
HumanOptics AG
DGAP-DD: HumanOptics AG english
27 August 2020
HumanOptics AG
HumanOptics AG: Preliminary business figures 2019/2020: Effects of COVID 19 pandemic weigh on sales and earnings
20 April 2020
HumanOptics AG
HumanOptics AG: Dr. Pierre Billardon leaves the Management Board on 30 April 2020; Diana Bachmann appointed as his successor
18 March 2020
HumanOptics AG
HumanOptics AG: Capital increase from authorized capital with subscription rights excluded against cash contribution planned; sustainable strengthening of equity capital basis
19 February 2020
HumanOptics AG
HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)
10 February 2020
HumanOptics AG
HumanOptics AG: Correction of the expected earnings forecast for the current financial year 2019/2020
23 January 2020
HumanOptics AG
HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval
19 December 2019
HumanOptics AG
HumanOptics AG: Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG
18 December 2019
HumanOptics AG
HumanOptics AG: Chinese investor new majority shareholder of HumanOptics AG – Closing of the share purchase agreement dated 30 August 2019 between Medipart AG and a Chinese investor regarding the majority stake in HumanOptics AG
30 August 2019
HumanOptics AG
HumanOptics AG: Majority stake in HumanOptics AG to be sold to Chinese investor
9 August 2019
HumanOptics AG
HumanOptics AG: Kapitalerhöhung aus genehmigten Kapital unter Bezugsrechtsausschluss gegen Bareinlage geplant; nachhaltige Stärkung der Eigenkapitalbasis
30 November 2018
HumanOptics AG
HumanOptics AG: Capital increase from authorized capital planned with exclusion of subscription rights; sustainable strengthening of equity base through conversion of liabilities
26 October 2018
HumanOptics AG
HumanOptics AG eröffnet sich Potenziale für eine wachstums- und ertragsstarke Zukunft
24 August 2018
HumanOptics AG
HumanOptics AG: Jahresergebnis für das Geschäftsjahr 2017/2018 durch Sonderaufwendungen belastet
31 May 2018
HumanOptics AG
Artificial Iris of HumanOptics Received FDA Approval
HumanOptics AG
Künstliche Iris von HumanOptics erhält FDA-Zulassung
6 March 2018
HumanOptics AG
HumanOptics AG: Rainer Stötzel verlässt den Vorstand zum 30. Juni 2018
24 October 2017
HumanOptics AG
HumanOptics AG gewinnt weiteren strategischen Investor / Erweiterung des Aufsichtsrats vorgesehen
16 October 2017
HumanOptics AG
HumanOptics AG auf Wachstumskurs
8 June 2017
HumanOptics AG
HumanOptics AG: Dr. Arthur Meßner verlässt den Vorstand der HumanOptics AG
25 January 2017
HumanOptics AG
DGAP-DD: HumanOptics AG english
10 January 2017
HumanOptics AG
HumanOptics AG erweitert den Vorstand und beruft neuen CEO
20 October 2016
HumanOptics AG
HumanOptics AG beschließt und platziert Barkapitalerhöhung
6 October 2016
HumanOptics AG
HumanOptics AG blickt auf ein erfolgreiches Geschäftsjahr 2015/2016 zurück